W. Alberto Sifuentes Giraldo: EULAR 2025 Key Recommendations for Behçet’s Syndrome Management
W. Alberto Sifuentes Giraldo, Rheumatologist at Hospital Nuestra Señora de Sonsoles (Sacyl), shared a post on LinkedIn about a recent article by Gulen Hatemi, adding:
“The 2025 update of EULAR recommendations for the management of Behçet’s syndrome, recently published in Annals of the Rheumatic Diseases, include 5 overarching principles and 12 recommendations organised by organ involvement.
Overarching principles stress the relapsing-remitting nature of the disease, individualised treatment based on activity and prognostic factors, a multidisciplinary approach, patient education, and shared decision-making.
Key recommendations:
- Mucocutaneous and joint involvement: Colchicine is first-line; apremilast or TNFα inhibitors for refractory cases.
- Organ-threatening disease: Early aggressive therapy with glucocorticoids and immunosuppressives, with prompt use of monoclonal TNFα inhibitors encouraged for severe or life-threatening manifestations.
Of the 12 recommendations, 1 is entirely new, 7 were modified, and 4 had only wording changes.”
Title: EULAR recommendations for the management of Behçet’s syndrome: 2025 update
Authors: Gulen Hatemi, Sofia Ramiro, Yesim Ozguler, Sinem Nihal Esatoglu, Gunnar Tomasson, Stephane Barete, Alessandra Bettiol, Bahram Bodaghi, Vladimira Boyadzhieva, Luca Cantarini, Aykut Ferhat Celik, Omar Dhrif, Georgina Ducker, Giacomo Emmi, Ahmet Gül, Jörg Henes, Ina Koetter, Martin Krusche, Giuseppe Lopalco, Robert J. Moots, David Saadoun, Carlo Salvarani, Petros Sfikakis, Aleksandra Stefanovic, Rosaria Talarico, Ilknur Tugal-Tutkun, Ugur Uygunoglu, Qianyu Zhao, Hasan Yazici
Read the Full Article on Annals of the Rheumatic Diseases.

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 9, 2026, 19:20Bradley Maron: The Beginning of a New Chapter for Circulation
-
Jul 9, 2026, 19:00Wolfgang Miesbach: ISTH 2026 Showcases the Future of Gene Therapy
-
Jul 9, 2026, 18:21Martin Vanden Eede: Can We Safely Reduce Anticoagulation During ECMO?
-
Jul 9, 2026, 18:00Dorothée Faille: Discovering Versailles During ISTH 2026
-
Jul 9, 2026, 16:45Rutbaa Ayaz Shaikh: One Step Further in Medical Research
-
Jul 9, 2026, 14:49Celebrating a Century of von Willebrand Disease Research and Care – Seminars in Thrombosis and Hemostasis
-
Jul 9, 2026, 14:38Valance Washington: International Hemostasis Community Prepares for GRC 2026
-
Jul 9, 2026, 14:27Dima Shulkin: Next-Generation AI Models Improve Early Sepsis Recognition
-
Jul 9, 2026, 14:12Omar Hajji: Seasonal Determinants of Mortality in Sepsis and Cardiogenic Shock